CLDI - Calidi Biotherapeutics, Inc.
0.431
-0.004 -0.905%
Share volume: 271,322
Last Updated: 05-07-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.43
0.00
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-21-2023 | 11-12-2024 | 05-14-2024 | 08-13-2024 | 11-12-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 0.000 | 6.537 M | 7.221 M | 0.000 | 5.772 M | 5.226 M | |
| Selling general and admin | 0.000 | 3.360 M | 3.970 M | 0.000 | 3.605 M | 3.073 M | |
| Research and development | 0.000 | 3.177 M | 3.251 M | 0.000 | 2.167 M | 2.153 M | |
| Total expenses | 5.414 M | 6.537 M | 7.221 M | 6.752 M | 5.772 M | 5.226 M | |
| 20.74% | 10.46% | -6.49% | -14.51% | -9.46% | |||
| Operating income | -5.414 M | -6.537 M | -7.221 M | -6.752 M | -5.772 M | -5.226 M | |
| Ebit | -5.414 M | -12.191 M | -1.218 M | -6.752 M | -5.762 M | -4.838 M | |
| Pretax income | -6.458 M | -12.497 M | -2.013 M | -7.221 M | -5.759 M | -5.070 M | |
| 93.51% | -83.89% | 258.72% | -20.25% | -11.96% | |||
| Income tax | 4.000 K | 4.000 K | 11.000 K | 4.000 K | 8.000 K | -1.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -6.462 M | -12.501 M | -2.024 M | -7.225 M | -5.767 M | -5.069 M | |
| -93.45% | 83.81% | -256.97% | 20.18% | 12.10% |
